Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body

1. UNAIDS (2013) Global Report: UNAIDS report on the global AIDS epidemic 2013. 2013 edition. Online: Joint United Nations Programme on HIV/AIDS. Available: http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport/. Accessed 7 April 2014.

2. BoilyMC, BaggaleyRF, WangL, MasseB, WhiteRG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118–129.

3. KeeleBF, EstesJD (2011) Barriers to mucosal transmission of immunodeficiency viruses. Blood 118: 839–846.

4. LiH, BarKJ, WangS, DeckerJM, ChenY, et al. (2010) High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 6: e1000890.

5. ParrishNF, GaoF, LiH, GiorgiEE, BarbianHJ, et al. (2013) Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 110: 6626–6633.

6. RajA, van OudenaardenA (2008) Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135: 216–226.

7. SallustoF, LanzavecchiaA (2009) Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 39: 2076–2082.

8. ReillyC, SchackerT, HaaseAT, WietgrefeS, KrasonD (2002) The Clustering of Infected SIV Cells in Lymphatic Tissue. J Am Stat Assoc 97: 943–954.

9. LiQ, EstesJD, SchlievertPM, DuanL, BrosnahanAJ, et al. (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034–1038.

10. ZhangZQ, WietgrefeSW, LiQ, ShoreMD, DuanL, et al. (2004) Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101: 5640–5645.

11. ZhuJ, PaulWE (2010) Heterogeneity and plasticity of T helper cells. Cell Res 20: 4–12.

12. AltschulerSJ, WuLF (2010) Cellular heterogeneity: do differences make a difference? Cell 141: 559–563.

13. McKinnonLR, KaulR (2012) Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Curr Opin HIV AIDS 7: 195–202.

14. Lloyd-SmithJO, SchreiberSJ, KoppPE, GetzWM (2005) Superspreading and the effect of individual variation on disease emergence. Nature 438: 355–359.

15. Anderson RM, May RM (1991) Infectious diseases of humans: dynamics and control. New York: Oxford University Press.

16. Keeling MJ, Rohani P (2008) Modeling infectious diseases in humans and animals. Princeton: Princeton University Press. xi, 366 pp.

17. De SerresG, MarkowskiF, TothE, LandryM, AugerD, et al. (2013) Largest measles epidemic in North America in a decade–Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis 207: 990–998.

18. SteinRA (2011) Super-spreaders in infectious diseases. Int J Infect Dis 15: e510–513.

19. Centers for Disease Control and Prevention (2003) Severe acute respiratory syndrome–Singapore, 2003. MMWR Morb Mortal Wkly Rep 52: 405–411.

20. RibeiroRM, QinL, ChavezLL, LiD, SelfSG, et al. (2010) Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol 84: 6096–6102.

21. AndersonD, PolitchJA, PudneyJ (2011) HIV infection and immune defense of the penis. Am J Reprod Immunol 65: 220–229.

22. LiuA, YangY, LiuL, MengZ, LiL, et al. (2014) Differential Compartmentalization of HIV-Targeting Immune Cells in Inner and Outer Foreskin Tissue. PLoS One 9: e85176.

23. PattersonBK, LandayA, SiegelJN, FlenerZ, PessisD, et al. (2002) Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 161: 867–873.

24. SabaE, GrivelJC, VanpouilleC, BrichacekB, FitzgeraldW, et al. (2010) HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. Mucosal Immunol 3: 280–290.

25. McKinnonLR, NyangaB, ChegeD, IzullaP, KimaniM, et al. (2011) Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 187: 6032–6042.

26. GrivelJC, ElliottJ, LiscoA, BiancottoA, CondackC, et al. (2007) HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 21: 1263–1272.

27. PudneyJ, QuayleAJ, AndersonDJ (2005) Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73: 1253–1263.

28. StrainMC, RichmanDD, WongJK, LevineH (2002) Spatiotemporal dynamics of HIV propagation. J Theor Biol 218: 85–96.

29. SnijderB, SacherR, RamoP, DammEM, LiberaliP, et al. (2009) Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 461: 520–523.

30. SnijderB, SacherR, RamoP, LiberaliP, MenchK, et al. (2012) Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 8: 579.

31. ZhongP, AgostoLM, MunroJB, MothesW (2013) Cell-to-cell transmission of viruses. Curr Opin Virol 3: 44–50.

32. SagarM (2010) HIV-1 transmission biology: selection and characteristics of infecting viruses. J Infect Dis 202 Suppl 2: S289–296.

33. LeeB, SharronM, MontanerLJ, WeissmanD, DomsRW (1999) Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A 96: 5215–5220.

34. ChenJ, DangQ, UnutmazD, PathakVK, MaldarelliF, et al. (2005) Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol 79: 4140–4149.

35. KabatD, KozakSL, WehrlyK, ChesebroB (1994) Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol 68: 2570–2577.

36. ParkerZF, IyerSS, WilenCB, ParrishNF, ChikereKC, et al. (2013) Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. J Virol 87: 2401–2411.

37. JohnstonSH, LobritzMA, NguyenS, LassenK, DelairS, et al. (2009) A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J Virol 83: 11016–11026.

38. BozekK, EckhardtM, SierraS, AndersM, KaiserR, et al. (2012) An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data. Retrovirology 9: 60.

39. ArthosJ, CicalaC, MartinelliE, MacleodK, Van RykD, et al. (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9: 301–309.

40. CicalaC, MartinelliE, McNallyJP, GoodeDJ, GopaulR, et al. (2009) The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 106: 20877–20882.

41. HarrisRS, HultquistJF, EvansDT (2012) The restriction factors of human immunodeficiency virus. J Biol Chem 287: 40875–40883.

42. WangX, AbuduA, SonS, DangY, VentaPJ, et al. (2011) Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. J Virol 85: 3142–3152.

43. MousK, JennesW, De RooA, PintelonI, KestensL, et al. (2011) Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry. J Immunol Methods 372: 52–64.

44. PanX, BaldaufHM, KepplerOT, FacklerOT (2013) Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes. Cell Res 23: 876–885.

45. MarquardtA, HalleS, SeckertCK, LemmermannNA, VeresTZ, et al. (2011) Single cell detection of latent cytomegalovirus reactivation in host tissue. J Gen Virol 92: 1279–1291.

46. WeinbergerLS, BurnettJC, ToettcherJE, ArkinAP, SchafferDV (2005) Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122: 169–182.

47. SchroderAR, ShinnP, ChenH, BerryC, EckerJR, et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521–529.

48. MitchellRS, BeitzelBF, SchroderAR, ShinnP, ChenH, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: e234.

49. WuX, LiY, CriseB, BurgessSM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749–1751.

50. SkupskyR, BurnettJC, FoleyJE, SchafferDV, ArkinAP (2010) HIV promoter integration site primarily modulates transcriptional burst size rather than frequency. PLoS Comput Biol 6: e1000952.

51. JosefssonL, PalmerS, FariaNR, LemeyP, CasazzaJ, et al. (2013) Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule. PLoS Pathog 9: e1003432.

52. JungA, MaierR, VartanianJP, BocharovG, JungV, et al. (2002) Recombination: Multiply infected spleen cells in HIV patients. Nature 418: 144.

53. HaigwoodNL (2009) Update on animal models for HIV research. Eur J Immunol 39: 1994–1999.

54. PanLZ, WernerA, LevyJA (1993) Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J Clin Microbiol 31: 283–288.

55. MillerCJ, MarthasM, TortenJ, AlexanderNJ, MooreJP, et al. (1994) Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 68: 6391–6400.

56. El HedA, KhaitanA, KozhayaL, ManelN, DaskalakisD, et al. (2010) Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis 201: 843–854.

57. MonteiroP, GosselinA, WaclecheVS, El-FarM, SaidEA, et al. (2011) Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immunol 186: 4618–4630.

58. AlvarezY, TuenM, ShenG, NawazF, ArthosJ, et al. (2013) Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J Virol 87: 10843–10854.

59. ShawGM, HunterE (2012) HIV transmission. Cold Spring Harb Perspect Med 2: a006965.

60. DahabiehMS, OomsM, SimonV, SadowskiI (2013) A double-fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection. J Virol 87: 4716–4727.

61. DuvergerA, JonesJ, MayJ, Bibollet-RucheF, WagnerFA, et al. (2009) Determinants of the establishment of human immunodeficiency virus type 1 latency. J Virol 83: 3078–3093.

62. MillerCJ, LiQ, AbelK, KimEY, MaZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217–9227.

63. McChesneyMB, CollinsJR, LuD, LuX, TortenJ, et al. (1998) Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 72: 10029–10035.

64. MaZM, AbelK, RourkeT, WangY, MillerCJ (2004) A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 78: 14048–14052.

65. BeyrerC, ArtensteinAW, RugpaoS, StephensH, VanCottTC, et al. (1999) Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 179: 59–67.

66. KaulR, Rowland-JonesSL, KimaniJ, FowkeK, DongT, et al. (2001) New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79: 3–13.

67. HortonRE, BallTB, WachichiC, JaokoW, RutherfordWJ, et al. (2009) Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV. AIDS Res Hum Retroviruses 25: 83–92.

68. UberlaK (2008) HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection? PLoS Pathog 4: e1000114.

69. GoEP, HewawasamG, LiaoHX, ChenH, PingLH, et al. (2011) Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry. J Virol 85: 8270–8284.

70. GnanakaranS, BhattacharyaT, DanielsM, KeeleBF, HraberPT, et al. (2011) Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog 7: e1002209.

71. NawazF, CicalaC, Van RykD, BlockKE, JelicicK, et al. (2011) The genotype of early-transmitting HIV gp120s promotes alpha (4) beta(7)-reactivity, revealing alpha (4) beta(7) +/CD4+ T cells as key targets in mucosal transmission. PLoS Pathog 7: e1001301.

72. Pena-CruzV, EtemadB, ChatziandreouN, NyeinPH, StockS, et al. (2013) HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners. Retrovirology 10: 162.

73. EtemadB, GonzalezOA, McDonoughS, Pena-CruzV, SagarM (2013) Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of alpha4beta7 integrin. J Acquir Immune Defic Syndr 64: 249–253.

74. ReddAD, Collinson-StrengAN, ChatziandreouN, MullisCE, LaeyendeckerO, et al. (2012) Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J Infect Dis 206: 1433–1442.

75. ParrishNF, WilenCB, BanksLB, IyerSS, PfaffJM, et al. (2012) Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7. PLoS Pathog 8: e1002686.

76. MotaTM, MurrayJM, CenterRJ, PurcellDF, McCawJM (2012) Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission. Retrovirology 9: 54.

77. ShenC, DingM, RatnerD, MontelaroRC, ChenY, et al. (2012) Evaluation of cervical mucosa in transmission bottleneck during acute HIV-1 infection using a cervical tissue-based organ culture. PLoS One 7: e32539.

78. OchsenbauerC, EdmondsTG, DingH, KeeleBF, DeckerJ, et al. (2012) Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 86: 2715–2728.

79. PearsonJE, KrapivskyP, PerelsonAS (2011) Stochastic theory of early viral infection: continuous versus burst production of virions. PLoS Comput Biol 7: e1001058.

80. ZhangZ, SchulerT, ZupancicM, WietgrefeS, StaskusKA, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353–1357.

81. PerelsonAS, NeumannAU, MarkowitzM, LeonardJM, HoDD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582–1586.

82. ArchinNM, VaidyaNK, KurucJD, LibertyAL, WiegandA, et al. (2012) Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A 109: 9523–9528.

83. HaaseAT (2011) Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 62: 127–139.

84. FunderburgNT, Stubblefield ParkSR, SungHC, HardyG, ClagettB, et al. (2013) Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 140: 87–97.

85. ChowellG, HengartnerNW, Castillo-ChavezC, FenimorePW, HymanJM (2004) The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol 229: 119–126.

86. KhanAS, TshiokoFK, HeymannDL, Le GuennoB, NabethP, et al. (1999) The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 Suppl 1: S76–86.

87. ChristensenPE, SchmidtH, BangHO, AndersenV, JordalB, et al. (1953) An epidemic of measles in southern Greenland, 1951; measles in virgin soil. II. The epidemic proper. Acta Med Scand 144: 430–449.

88. ChenRT, GoldbaumGM, WassilakSG, MarkowitzLE, OrensteinWA (1989) An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol 129: 173–182.

89. GaniR, LeachS (2004) Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerg Infect Dis 10: 608–614.

90. TiehTH, LandauerE, et al. (1948) Primary pneumonic plague in Mukden, 1946, and report of 39 cases with three recoveries. J Infect Dis 82: 52–58.

91. BauchCT, Lloyd-SmithJO, CoffeeMP, GalvaniAP (2005) Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 16: 791–801.

92. YuIT, LiY, WongTW, TamW, ChanAT, et al. (2004) Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 350: 1731–1739.

93. Kamps BS, Hoffmann C, editors (2005) SARS Reference. 3rd edition. Flying Publisher.

94. VariaM, WilsonS, SarwalS, McGeerA, GournisE, et al. (2003) Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 169: 285–292.

95. GaniR, LeachS (2001) Transmission potential of smallpox in contemporary populations. Nature 414: 748–751.

96. Fenner F (1988) Smallpox and its eradication. Geneva: World Health Organization. xvi, 1460 pp.